AgForce Enables Antigen-conditioned Generative Antibody Design

• URL: http://arxiv.org/abs/2605.21610v1
• Date: Wed, 20 May 2026 18:16:52 GMT
• Title: AgForce Enables Antigen-conditioned Generative Antibody Design
• Abstract summary: We propose a novel encoder-decoder architecture called AgForce.<n>It uses a graph neural network (GNN) as the encoder and specialized decoders for sequence-structure co-design.<n>It achieves the best binding quality and sequence recovery simultaneously on the CHIMERA-Bench dataset.
• Score: 3.2018287682779003
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Antibody design methods condition on antigen structure to generate complementarity-determining regions (CDR), yet a systematic evaluation of baseline methods reveals that they largely ignore the antigen input. We identify three failure modes that explain this behavior. Antigen blindness arises because models derive predictions from antibody framework context rather than antigen information, producing nearly identical CDRs regardless of the target. Vocabulary collapse reduces predicted amino acids to three to five per position, far below the ground truth distribution in native sequences. Moreover, any model trained with standard per-position cross-entropy converges to the positional marginal distribution, making it provably unable to produce antigen-specific sequence predictions. We propose a novel encoder-decoder architecture called AgForce, that uses a graph neural network (GNN) as the encoder and specialized decoders for sequence-structure co-design. Specifically, we apply framework dropout, gated bottlenecks, and hyperbolic cross attention that prevent the antibody shortcut path. In the decoder, a Mixture Density Network (MDN) sequence head with Potts-like pairwise coupling and annealed Multiple Choice Learning (aMCL) replaces the cross-entropy objective with a multi-component distribution whose optimal solution differs from the positional marginal. An antigen cycle consistency head routes gradients through the sequence decoder, forcing predicted distributions to encode antigen identity. AgForce achieves the best binding quality and sequence recovery simultaneously on the CHIMERA-Bench dataset, improving amino acid recovery by 8% over the strongest sequence baseline while surpassing the baselines across all interface metrics, and nearly doubling the effective vocabulary of GNN methods. The source code is available at: https://github.com/mansoor181/ag-force.git

Related papers

• LoRC: Detecting AI-Generated Images via Low-Rank Collapse in Semantic Residuals [50.157719466558696]
  We show that modern generators exhibit low-rank collapse in the semantic-residual subspace while preserving the dominant semantic direction.<n>We propose textbfLoRC, a framework that decouples semantic dominance to capture the collapsed residual geometry.<n>Our method improves accuracy by an average of 7.0% across multiple benchmarks and achieves 97.0% accuracy on 39 unseen generators.
  arXiv  Detail & Related papers  (2026-08-21T08:58:47Z)
• EpiFormer: Learning Antigen-Antibody Interactions for Epitope Prediction via Geometric Deep Learning [5.747428107106341]
  EpiFormer is a general-variant-decoder framework for antibody prediction.<n>It improves over the previous best method by over 40% in F1 score on standard benchmarks.<n>EpiFormer discovers known biological principles as emergent behaviors of end-to-end training.
  arXiv  Detail & Related papers  (2026-06-02T19:20:25Z)
• Fusing Sequence Motifs and Pan-Genomic Features: Antimicrobial Resistance Prediction using an Explainable Lightweight 1D CNN-XGBoost Ensemble [0.0]
  Antimicrobial Resistance (AMR) is a rapidly escalating global health crisis.<n>Standard machine learning models treat the genome as an unordered collection of features.<n>We propose AMR-EnsembleNet, an ensemble framework that combines sequence-based and feature-based learning.
  arXiv  Detail & Related papers  (2025-09-28T01:19:11Z)
• AntibodyFlow: Normalizing Flow Model for Designing Antibody Complementarity-Determining Regions [9.427196604657215]
  Therapeutic antibodies are specialized protective proteins that bind to antigens in a lock-to-key manner. The binding strength/affinity between an antibody and a specific antigen is heavily determined by the complementarity-determining regions (CDRs) on the antibodies. Existing machine learning methods cast in silico development of CDRs as either sequence or 3D graph (with a single chain) generation tasks.
  arXiv  Detail & Related papers  (2024-06-19T02:31:23Z)
• xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
  We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence. The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
  arXiv  Detail & Related papers  (2022-11-30T09:26:08Z)
• Incorporating Pre-training Paradigm for Antibody Sequence-Structure Co-design [134.65287929316673]
  Deep learning-based computational antibody design has attracted popular attention since it automatically mines the antibody patterns from data that could be complementary to human experiences. The computational methods heavily rely on high-quality antibody structure data, which is quite limited. Fortunately, there exists a large amount of sequence data of antibodies that can help model the CDR and alleviate the reliance on structure data.
  arXiv  Detail & Related papers  (2022-10-26T15:31:36Z)
• Reprogramming Pretrained Language Models for Antibody Sequence Infilling [72.13295049594585]
  Computational design of antibodies involves generating novel and diverse sequences, while maintaining structural consistency. Recent deep learning models have shown impressive results, however the limited number of known antibody sequence/structure pairs frequently leads to degraded performance. In our work we address this challenge by leveraging Model Reprogramming (MR), which repurposes pretrained models on a source language to adapt to the tasks that are in a different language and have scarce data.
  arXiv  Detail & Related papers  (2022-10-05T20:44:55Z)
• Conditional Antibody Design as 3D Equivariant Graph Translation [28.199522831859998]
  We propose Multi-channel Equivariant Attention Network (MEAN) to co-design 1D sequences and 3D structures of CDRs. Our method significantly surpasses state-of-the-art models in sequence and structure modeling, antigen-binding CDR design, and binding affinity optimization.
  arXiv  Detail & Related papers  (2022-08-12T01:00:59Z)
• Antibody-Antigen Docking and Design via Hierarchical Equivariant Refinement [38.637412590671865]
  We propose a new model called Hierarchical Equivariant Refinement Network (HERN) for paratope docking and design. During docking, HERN employs a hierarchical message passing network to predict atomic forces and use them to refine a binding complex in an iterative, equivariant manner. Our results show that HERN significantly outperforms prior state-of-the-art on paratope docking and design benchmarks.
  arXiv  Detail & Related papers  (2022-07-14T02:13:25Z)
• Discriminator-Free Generative Adversarial Attack [87.71852388383242]
  Agenerative-based adversarial attacks can get rid of this limitation. ASymmetric Saliency-based Auto-Encoder (SSAE) generates the perturbations. The adversarial examples generated by SSAE not only make thewidely-used models collapse, but also achieves good visual quality.
  arXiv  Detail & Related papers  (2021-07-20T01:55:21Z)
• Class-Conditional Defense GAN Against End-to-End Speech Attacks [82.21746840893658]
  We propose a novel approach against end-to-end adversarial attacks developed to fool advanced speech-to-text systems such as DeepSpeech and Lingvo. Unlike conventional defense approaches, the proposed approach does not directly employ low-level transformations such as autoencoding a given input signal. Our defense-GAN considerably outperforms conventional defense algorithms in terms of word error rate and sentence level recognition accuracy.
  arXiv  Detail & Related papers  (2020-10-22T00:02:02Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.